COO - Cooper Companies, Inc.
SNP 500


Moderate Growth but Declining


based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 4.63%
Operating Income Growth is 4.71%
Net Income Growth is 586.39%
Earnings Per Share (EPS) Growth is 590.39%
Net Margin is 88.54%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.33
Debt Ratio is 0.32
Current Debt to Net Income Ratio is 3.51
Total Debt to Total Assets Ratio is 0.19
Cash Flow is STRONG
Cash from Operations Growth is 21.61%
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Cooper Companies, Inc. (COO) -
CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Albert White
Employees - 12,000

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.